BioSpace News Archive

.Radiopharmaceuticals have recently been making headlines due to their potential in medical imaging and targeted therapies.

TrialSpark, Inc. announced today that the first patient has been dosed in its Phase 2 clinical trial for ASN008-201, a topical sodium channel blocker in development for pruritus associated with atopic dermatitis (AD).

iPredictTM AI Eye Screening System provides fully automated age-related macular degeneration (AMD) screening, including retinal imaging and immediate reporting of actionable results.

To better explain the prevalence and cause of clots, researchers from The Feinstein Institutes for Medical Research investigated the rates of clotting 90 days after patients leave the hospital.

SCIEX, a global leader in life science analytical technologies, celebrates the opening of the Echo® MS Center of Excellence.

Indivior PLC announced that its registration statement on Form 20-F required for the additional U.S. listing of its ordinary shares is now available at www.sec.gov and under the “Investors” section of the Company’s website.

Curium, a world leader in nuclear medicine, announced today that it has completed enrollment in its USA-led SOLAR Phase 1/2 study evaluating the safety, biodistribution, and image quality of Copper Cu64 PSMA I&T injection to detect metastatic prostate cancer in PET imaging.

Waters Corporation announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time.

Zambon announced that the Company presented results from a study evaluating the humanistic burden of bronchiolitis obliterans syndrome after lung transplant or allogeneic hematopoietic stem cell transplantation at the American Thoracic Society 2023 Annual Meeting being held May 19 - 24, 2023 in Washington, D.C.

Quest Diagnostics is proud to support Americares in their efforts to improve health for people affected by poverty or disaster with a grant from Quest for Health Equity.